Amicogen Inc. | |
Stock Exchange | Korea Exchange |
EPS |
KRW759.5 |
Market Cap |
KRW792.61 B |
Shares Outstanding |
19.19 M |
Public Float |
13.28 M |
Address |
64 Dongbu-ro 1259 beon-gil Jinju SG 52621 Korea, Republic Of |
Employees | - |
Website | http://www.amicogen.com |
Updated | 09/14/2018 |
Amicogen, Inc. engages in the development and marketing of enzyme products and functional food materials. Its products include specialty enzyme for pharmaceutical, food, feed and industrial; new bio-ingredient such as natural health ingredients for food, feed and cosmetics, finished products; and immunological products such as protein A resin, anticancer treatment vaccine based on B cell and mononuclear cell, and POCT immune diagnosis device using innovative C-ECL technology. It also engages in original equipment manufacturing and original development manufacturing of nutraceutical products. |